A solution to part of the Cohen-Lenstra conjecture helps resolve a long-standing mystery about quadratic forms ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

SAN FRANCISCO (AP) — Mike Trout has his first four-hit game in more than five years while moving past Tim Salmon on the Los Angeles Angels’ career doubles and singles lists. Trout went 4 for 4 in the ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about their dangers. “We are not there yet, and recursive self-improvement is not ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Months after ByHeart’s recall ended, how the bacteria got in the powdered infant formula remains unknown. A separate recall by Nara Organics is now under investigation. Angel Carter had breastfed her ...

Jade Bryan is a Feature Author at Android Police with over a decade of tech reviews and news reporting experience, stretching back to the Symbian era and the early days of Android. He covers the ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

RSI is also defined as an “AI system capable of fully autonomously designing and developing its own successor,” per Anthropic’s blog post. “We are not there yet, and recursive self-improvement is not ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...